Revlimid (lenalidomide) is a brand-name oral capsule that’s prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...
On a busy morning after Bristol Myers Squibb revealed that the FDA approved its potential blockbuster Camzyos, the pharma giant also introduced negative news about a fading blockbuster. Sales of ...
Three months ago, when Bristol Myers Squibb, dropped its 2022 Revlimid sales estimate by $500 million, it was an ominous sign that the aging multiple myeloma drug was fading fast under its initial ...
Celgene Corporation (NASDAQ: CELG) announced updated clinical data from two Phase III pivotal studies evaluating REVLIMID (lenalidomide) plus dexamethasone in previously treated multiple myeloma ...
BOSTON, Dec 1 (Reuters) - Sales of Celgene Corp's cancer drug Revlimid could rise by more than a third if data due to be presented next Monday at the annual meeting of the American Society of ...
For patients with B-cell lymphoma, the addition of Revlimid to standard R-CHOP did not improve progression-free survival nor event-free survival. The addition of Revlimid (lenalidomide) to standard ...
BOSTON, Dec 7 (Reuters) - Celgene Corp said on Monday that a trial of its cancer drug Revlimid showed it reduced the risk of disease progression in newly diagnosed patients with multiple myeloma by 50 ...
Australian biotech HaemaLogix has posted phase 2b data that show its monoclonal antibody “significantly” improves response rates for multiple myeloma patients when paired with Revlimid. The 40-person ...
Summit, N.J., June 29 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdaq: CELG) announced that the U.S. Food and Drug Administration (FDA) has granted approval for ...
Dr. Reddy’s is introducing lenalidomide capsules, a generic of Revlimid. With this volume-limited launch, Dr. Reddy’s is eligible for first to market, 180 days of generic drug exclusivity for ...
Alvogen licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March 2022 date Celgene previously granted to Natco Alvogen also licensed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results